By |

Profile

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.

Contact Information

Website: www.uniqure.com
Email: M.Cantor@uniQure.com
Main Phone: +31 202406000
Address: Paasheuvelweg 25a
City / Town: Amsterdam
Country: NLD
Postal Code: 1105 BP

Issuer Information

Exchange: NGS
CEO: Matthew C. Kapusta
Employees: 216


Gathering Data... Please wait

Profile

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.

Contact Information

Website: www.uniqure.com
Email: M.Cantor@uniQure.com
Main Phone: +31 202406000
Address: Paasheuvelweg 25a
City / Town: Amsterdam
Country: NLD
Postal Code: 1105 BP

Issuer Information

Exchange: NGS
CEO: Matthew C. Kapusta
Employees: 216
$ 62.99 $ 0.30 (0.48%)
Last Price 62.99 Change $ 0.30 Change % 0.48 Tick N/A
Bid 54.10 Bid Size 100.00 Ask 100.00 Ask Size 100.00
Open 63.30 High 64.86 Low 62.16 Prev Close 62.69
Last Trade Volume 490,746 52 Wk Hi 69.60 52 Wk Low 21.98
Market Cap 2.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,799,249.00 EPS (TTM) -2.49 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 39
Number of Buys 0 24
Number of Sells 1 15
Net Activity -23929 453197
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Steven Zelenkofske 1,000
Matthew C. Kapusta 1,000
Jack Kaye 1,000
David Schaffer 1,000
Paula Soteropoulos 1,000
Philip Astley-Sparke 1,000
Sander van Deventer 1,000
Matthew C. Kapusta 1,000
Jonathan Garen 1,000
Paul E. Firuta 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 63 63 63 63
Low Target Price Estimate 37 37 37 37
Mean Target Price Estimate 45.83 45.83 45.4 45.83
Standard Deviation 9.54 9.54 10.6 9.54
Date of Most Recent Estimate 05/24/18 05/24/18 05/22/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 7 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1